Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

Clinical trial NCT00162097 · COMPLETED

Trial details

NCT number: NCT00162097
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV Infections Hepatic Impairment

Start date: 2004-11-01
Primary completion: 2008-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.